| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |